Voleon Capital Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Voleon Capital Management's ABBV Position: Q3 2026 in Review
Voleon Capital Management reduced its AbbVie (ABBV) stake by 45% in Q3 2026, selling an estimated $19.8M and leaving 95,643 shares worth $25M. The position accounts for 0.45% of the portfolio, ranked #46.
Voleon Capital Management first reported a position in ABBV in Q2 2019 and has held it in 9 quarters since. The position peaked at $43.5M in Q2 2026. 4,192 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.
- Voleon Capital Management held 95,643 shares of AbbVie worth $25M as of Q3 2026.
- Voleon Capital Management sold 77,110 AbbVie shares in Q3 2026, an estimated $19.8M.
- AbbVie made up 0.45% of Voleon Capital Management's portfolio in Q3 2026, its #46 holding.
- Voleon Capital Management first reported a position in AbbVie in Q2 2019 and has held it in 9 quarters since.
- Voleon Capital Management's AbbVie position peaked at $43.5M in Q2 2026.
- 4,192 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.
Based on Voleon Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.